Synergistic enhancement of chemokine generation and lung injury by C5a or the membrane attack complex of complement.

[1]  S. Rennard,et al.  Expression of receptors for C5a anaphylatoxin (CD88) on human bronchial epithelial cells: enhancement of C5a-mediated release of IL-8 upon exposure to cigarette smoke. , 1998, Journal of immunology.

[2]  A. Lentsch,et al.  NF-kappaB activation during IgG immune complex-induced lung injury: requirements for TNF-alpha and IL-1beta but not complement. , 1998, The American journal of pathology.

[3]  C. Mold Cellular Responses to the Membrane Attack Complex , 1998 .

[4]  A. Lentsch,et al.  In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. , 1997, The Journal of clinical investigation.

[5]  K. Laupland,et al.  Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism. , 1997, The Journal of clinical investigation.

[6]  P. Ward,et al.  Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation. , 1997, The American journal of pathology.

[7]  P. Ward,et al.  Requirement for C-X-C chemokines (macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant) in IgG immune complex-induced lung injury. , 1997, Journal of immunology.

[8]  P. Ward,et al.  C5a-dependent up-regulation in vivo of lung vascular P-selectin. , 1997, Journal of immunology.

[9]  P. Ward,et al.  Rous-Whipple Award Lecture. Role of complement in lung inflammatory injury. , 1996, The American journal of pathology.

[10]  J. Christman,et al.  In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. , 1996, Journal of immunology.

[11]  P. Ward,et al.  Requirement and role of C5a in acute lung inflammatory injury in rats. , 1996, The Journal of clinical investigation.

[12]  P. Ward,et al.  Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1. , 1995, Journal of immunology.

[13]  P. Ward,et al.  Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase. , 1995, American journal of respiratory cell and molecular biology.

[14]  P. Ward,et al.  Role of macrophage inflammatory protein-1 alpha (MIP-1 alpha) in acute lung injury in rats. , 1995, Journal of immunology.

[15]  R. Wetsel Expression of the complement C5a anaphylatoxin receptor (C5aR) on non-myeloid cells. , 1995, Immunology letters.

[16]  P. Ward,et al.  C5a-induced expression of P-selectin in endothelial cells. , 1994, The Journal of clinical investigation.

[17]  J. Ravetch,et al.  Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. , 1994, Science.

[18]  T. Hugli,et al.  Primary structure and functional characterization of rat C5a: An anaphylatoxin with unusually high potency , 1994, Protein science : a publication of the Protein Society.

[19]  F. Gannon,et al.  A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. , 1994, BioTechniques.

[20]  J. Hiscott,et al.  Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop , 1993, Molecular and cellular biology.

[21]  M. Plumb,et al.  C/EBP, NF-kappa B, and c-Ets family members and transcriptional regulation of the cell-specific and inducible macrophage inflammatory protein 1 alpha immediate-early gene , 1993, Molecular and cellular biology.

[22]  T. Standiford,et al.  MCP-1 expression by rat type II alveolar epithelial cells in primary culture. , 1993, Journal of immunology.

[23]  R. Takigiku,et al.  Macrophage inflammatory proteins 1 and 2: expression by rat alveolar macrophages, fibroblasts, and epithelial cells and in rat lung after mineral dust exposure. , 1993, American journal of respiratory cell and molecular biology.

[24]  Cullen B. Owens,et al.  Superoxide responses of endothelial cells to C5a and TNF-alpha: divergent signal transduction pathways. , 1992, The American journal of physiology.

[25]  B. Zimmermann,et al.  Activation of the fifth component of human complement, C5, without cleavage, by methionine oxidizing agents. , 1992, Molecular immunology.

[26]  M. Frank,et al.  The role of complement in inflammation and phagocytosis. , 1991, Immunology today.

[27]  S. Murakami,et al.  Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements. , 1991, The Journal of biological chemistry.

[28]  K. Matsushima,et al.  Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. , 1990, The Journal of biological chemistry.

[29]  H. Hohmann,et al.  Tumor necrosis factors-alpha and -beta bind to the same two types of tumor necrosis factor receptors and maximally activate the transcription factor NF-kappa B at low receptor occupancy and within minutes after receptor binding. , 1990, The Journal of biological chemistry.

[30]  B. Morgan Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. , 1989, The Biochemical journal.

[31]  P. Sims,et al.  Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. , 1989, The Journal of biological chemistry.

[32]  M. Gawryl,et al.  Accentuated formation of the terminal C5b-9 complement complex in patient plasma precedes development of the adult respiratory distress syndrome. , 1988, The American review of respiratory disease.

[33]  J. Weigelt,et al.  Complement and the severity of pulmonary failure. , 1988, The Journal of trauma.

[34]  T. Espevik,et al.  A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. , 1986, Journal of immunological methods.

[35]  M. Mayer,et al.  The relationship between channel size and the number of C9 molecules in the C5b-9 complex. , 1985, Journal of immunology.

[36]  M. Lamy,et al.  Complement activation in patients at risk of developing the adult respiratory distress syndrome. , 1984, The American review of respiratory disease.

[37]  J. Monahan,et al.  Measurement of the ratio of the eighth and ninth components of human complement on complement-lysed membranes. , 1984, Biochemistry.

[38]  G. Larsen,et al.  Complement fragments, alveolar macrophages, and alveolitis. , 1979, The American journal of pathology.

[39]  P. Ward,et al.  Acute immunologic pulmonary alveolitis. , 1974, The Journal of clinical investigation.

[40]  A. Lentsch,et al.  In Vivo Suppression of NFk B and Preservation of I k B a by Interleukin-10 and Interleukin-13 , 1997 .

[41]  T. Lint,et al.  Accentuated complement activation in patient plasma during the adult respiratory distress syndrome: a potential mechanism for pulmonary inflammation. , 1989, Heart & lung : the journal of critical care.

[42]  M. Betz,et al.  Effect of the late complement components C5b-9 on human monocytes: release of prostanoids, oxygen radicals and of a factor inducing cell proliferation. , 1987, International archives of allergy and applied immunology.

[43]  P. Craddock Complement, granulocytes, and shock lung. , 1984, The American journal of emergency medicine.

[44]  J. Hiscott,et al.  Characterization of a Functional NF-KdB Site in the Human Interleukin 13 Promoter: Evidence for a Positive Autoregulatory Loop , 2022 .

[45]  M. Grove,et al.  C/EBP, NF-vB, and c-Ets Family Members and Transcriptional Regulation of the Cell-Specific and Inducible Macrophage Inflammatory Protein lot Immediate-Early Gene , 2022 .